Stem cell shot aims to seal Crohn's fistulas
NCT ID NCT06636032
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether injecting stem cells from donated fat tissue can help heal complex anal fistulas in people with Crohn's disease who haven't gotten better with standard treatments. Nine adults will receive the stem cell injection and be followed for six months to check for side effects and signs of healing. The goal is to see if this approach is safe and worth testing in larger studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- allogeneic adipose-derived mesenchymal stem cells (AdMSC)
- What this could lead to
- If it works, this could offer a new way to heal hard-to-treat anal fistulas in Crohn's disease without surgery or strong drugs.
- What could go wrong
- This is a very small, early-phase trial with only 9 people. It mainly checks safety, not effectiveness. The treatment may not work or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toulouse Hospital
RECRUITINGToulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a patient registry unlock the secrets of IBD?
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a Real-World study reveal the staying power of guselkumab?